| Marked seasonality of Cyclospora cayetanensis infections: ten-year observation of hospital cases, Honduras RG Kaminsky, J Lagos, G Raudales Santos, S Urrutia BMC infectious diseases 16, 1-9, 2015 | 40 | 2015 |
| Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia J Senapati, S Urrutia, S Loghavi, NJ Short, GC Issa, A Maiti, HA Abbas, ... Blood 142 (19), 1647-1657, 2023 | 36 | 2023 |
| Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low‐resource Central America setting V Ortiz, D Estevez‐Ordonez, E Montalvan‐Sanchez, S Urrutia‐Argueta, ... Helicobacter 24 (4), e12595, 2019 | 22 | 2019 |
| Validez de los métodos de predicción para riesgo cardiovascular en América Latina: revisión bibliográfica AA Rodríguez, AA Murillo, RJ Rivera, EE Montalván, KG Duarte, ... Revista Médica Hondureña 85 (1-2), 51-55, 2017 | 18 | 2017 |
| Clinical and biological effects of canakinumab in lower-risk myelodysplastic syndromes (MDS): results from a phase 2 clinical trial G Garcia-Manero, V Adema, S Urrutia, F Ma, H Yang, I Ganan-Gomez, ... Blood 140 (Supplement 1), 2078-2080, 2022 | 10 | 2022 |
| Congenital malformations of the central nervous system in rural Western Honduras: a 6-year report on trends D Estevez-Ordonez, MC Dewan, MJ Feldman, EE Montalvan-Sanchez, ... World neurosurgery 107, 249-254, 2017 | 10 | 2017 |
| Remarkable response to erdafitinib in metastatic lung adenocarcinoma with FGFR fusion SA Urrutia Argueta, NH Hanna ASCO, 2020 | 9 | 2020 |
| Cardiovascular risk assessment in the resource limited setting of Western Honduras: An epidemiological perspective EEM Sanchez, SA Urrutia, AA Rodriguez, G Duarte, A Murillo, R Rivera, ... IJC Heart & Vasculature 27, 100476, 2020 | 8 | 2020 |
| A phase 2 study of Canakinumab in patients with lower-risk myelodysplastic syndromes or chronic myelomonocytic leukemia JJR Sevilla, V Adema, KS Chien, I Ganan-Gomez, G Montalban-Bravo, ... Blood 142, 1866, 2023 | 7 | 2023 |
| Baseline predictors of hematological toxicity in patients with advanced cancer treated with ATR inhibitors in phase I/II clinical trials. N Ngoi, HY Lin, EE Dumbrava, S Fu, DD Karp, A Naing, S Pant, ... Journal of Clinical Oncology 40 (16_suppl), 3111-3111, 2022 | 7 | 2022 |
| Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly (ADP‐ribose) polymerase proteins inhibitors for solid tumours. E Almanza‐Huante, A Bataller, S Urrutia, G Gener‐Ricos, RE Briski, ... British Journal of Haematology 201 (3), 2023 | 6 | 2023 |
| Neurologic recovery in systemic nontraumatic fat embolism syndrome in an elderly patient with hemoglobin SC disease: a case report A Ositelu, S Urrutia‐Argueta, R Kapoor Clinical Case Reports 8 (9), 1816-1820, 2020 | 6 | 2020 |
| Clinical outcomes of heart transplantation using hepatitis c-viremic donors: A systematic review with meta-analysis J Villegas-Galaviz, E Anderson, M Guglin The Journal of Heart and Lung Transplantation 41 (4), 538-549, 2022 | 5 | 2022 |
| Survival of gastric cancer in western Honduras pilot study: 2002-2012 EE Montalván, DM Montalván, SA Urrutia, AA Rodríguez, H Sandoval, ... Revista Medica Hondurena 85 (1), 6-10, 2017 | 5 | 2017 |
| Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations S Urrutia, Z Li, E Almanza, A Bataller, R Kanagal-Shamanna, J Senapati, ... Leukemia 37 (6), 1397-1400, 2023 | 4 | 2023 |
| Lung cancer screening knowledge among internal medicine residents in a University Program S Urrutia Argueta, N Hanna Journal of Cancer Education 36 (6), 1186-1192, 2021 | 4 | 2021 |
| Precision medicine in AML: overcoming resistance S Urrutia, K Takahashi International journal of hematology 120 (4), 439-454, 2024 | 3 | 2024 |
| Dynamic changes in monocyte and reticulocyte counts predict mechanism-based anemia development and recovery during ATR inhibitor treatment in phase I/II trials NY Ngoi, HY Lin, E Dumbrava, S Fu, DD Karp, A Naing, S Pant, ... Cancer Research 83 (7_Supplement), 6181-6181, 2023 | 3 | 2023 |
| Clinical presentation and outcomes of hospitalized children with COVID‐19 in Mexico City DR Diaz, S Urrutia, G Gutierrez, F Cuevas Pediatric Pulmonology 57 (12), 3044-3049, 2022 | 3 | 2022 |
| Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax A Bazinet, SP Desikan, Z Li, JJ Rodriguez-Sevilla, S Venugopal, S Urrutia, ... Clinical cancer research: an official journal of the American Association …, 2024 | 2 | 2024 |
Koji Sasaki (佐々木 宏治)The University of Texas MD Anderson Cancer CenterEmail verificata su mdanderson.org